
|Articles|July 1, 2001
Senate swing favors patient bill of rights
The return of the U.S. Senate to Democratic control appears to improvethe chances for passage of a Patients' Bill of Rights, but it could reducechances for real Medicare reform as key Democratic leaders focus on prescriptiondrug legislation instead.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
2
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
3
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
4
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
5


















